Biohaven
BHVN
176 hedge funds and large institutions have $868M invested in Biohaven in 2022 Q4 according to their latest regulatory filings, with 146 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 22 closing their positions.
564% more first-time investments, than exits
New positions opened: 146 | Existing positions closed: 22
238% more funds holding
Funds holding: 52 → 176 (+124)
78% more ownership
Funds ownership: 13.63% → 91.63% (+78%)
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
62% more capital invested
Capital invested by funds: $535M → $868M (+$333M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
60% less call options, than puts
Call options by funds: $5.79M | Put options by funds: $14.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
+$79.4M |
| 2 |
BlackRock
New York
|
+$58.7M |
| 3 |
State Street
Boston,
Massachusetts
|
+$58M |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$53.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$50M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$153M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$74.9M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$36.9M |
| 4 |
WIC
Water Island Capital
New York
|
-$33.5M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$25.2M |
BHVN Hedge Fund Activity: Q4 2022 in Review
176 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q4 2022, worth a combined $868M — up 62% from $535M a quarter earlier.
Buyers outnumbered sellers: 146 funds opened new BHVN positions and 22 closed out — a net gain of 124 holders — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Stifel Financial, opening a new position worth an estimated $79.4M. The largest seller was Millennium Management, exiting entirely with an estimated $153M sold.
- 176 institutional investors held Biohaven (BHVN) as of Q4 2022, up from 52 in Q3 2022.
- Funds reported $868M of Biohaven stock for Q4 2022, up 62% quarter-over-quarter.
- 146 funds opened new Biohaven positions in Q4 2022 and 22 closed out, a net change of +124 holders.
- The largest Biohaven buyer in Q4 2022 was Stifel Financial, an estimated $79.4M added.
- The largest Biohaven seller in Q4 2022 was Millennium Management, an estimated $153M sold.
Based on aggregated 13F filings for Q4 2022.